1. Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
    Yingjun Zhang et al, 2024, Frontiers in Oncology CrossRef
  2. Efficient functional Lasso kernel smoothing for high-dimensional additive regression
    Eun Ryung Lee et al, 2024, The Annals of Statistics CrossRef
  3. CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer
    Xin-le Han et al, 2021, BioMed Research International CrossRef
  4. Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
    Wei Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  5. Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
    Atta Mohammed Alzebari et al, 2023, BioMed Target Journal CrossRef
  6. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
    Jianwei Feng et al, 2022, Frontiers in Pharmacology CrossRef
  7. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
    Bi Lian et al, 2023, Frontiers in Immunology CrossRef
  8. Anticancer clinical efficiency and stochastic mechanisms of belinostat
    Nasreddine El Omari et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  9. Effects of Radiotherapy in Combination With Irinotecan and 17-AAG on Bcl-2 and Caspase 3 Gene Expression in Colorectal Cancer Cells
    Mahnaz Ebrahimpour et al, 2022, Journal of Lasers in Medical Sciences CrossRef
  10. The role of protein acetylation in carcinogenesis and targeted drug discovery
    Jingru Yang et al, 2022, Frontiers in Endocrinology CrossRef
  11. Small-molecule dual inhibitors targeting heat shock protein 90 for cancer targeted therapy
    Xin Xie et al, 2023, Bioorganic Chemistry CrossRef
  12. Integrated pan-cancer analysis of centromere protein F and experimental verification of its role and clinical significance in cholangiocarcinoma
    Zhenyu Cao et al, 2023, Functional & Integrative Genomics CrossRef